Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Cytequest Inc. maintains a concentrated presence in the Chemistry & Materials technology area with 1 pending office action currently on the docket. This pending matter is being reviewed within 1 distinct art unit, indicating that the company's current patenting efforts are focused on a specific technical niche. The narrow scope of the portfolio's active prosecution suggests a streamlined approach to securing intellectual property rights.
The prosecution involves 1 distinct examiner, KRCHA, MATTHEW D, who is responsible for the 1 pending action identified as the busiest examiner workload. This relationship between the portfolio and the examiner means that the prosecution strategy is dependent on the feedback from this specific official. Practitioners can focus their efforts on understanding the specific preferences and prior art citations of this examiner to resolve the outstanding action.
Because the busiest examiner pending count matches the total pending office actions of 1, there is no fragmentation in the portfolio's current legal challenges. This centralization within the Chemistry & Materials sector allows for a dedicated response strategy. The success of the current prosecution cycle hinges on addressing the specific concerns raised in the office action currently under review by the assigned examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KRCHA, MATTHEW D | 1 | 64.3% | +35.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17965255 | DEVICES, METHODS, AND SYSTEMS FOR ELECTROPORATION USING CONTROLLED PARAMETERS | KRCHA, MATTHEW D | — |
| Art Unit | Apps |
|---|---|
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17965255 | DEVICES, METHODS, AND SYSTEMS FOR ELECTROPORATION USING CONTROLLED PARAMETERS | KRCHA, MATTHEW D | 1796 | §103 | Non-Final OA | — | Pending | Oct 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCytequest Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Matthew D Krcha has the most, with 1 of Cytequest Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
